MedPath

Flower Essences in relieving anxiety during labor.

Not Applicable
Conditions
Anxiety
F01.470.132
Registration Number
RBR-5tt55v
Lead Sponsor
Escola Paulista de Enfermagem-Universidade Federal de São Paulo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Do not have obstetric pathologies; Being in the active phase of labor, diagnosed on admission by the treatment team minimum 3 cm cervical dilatation and maximum of 8 cm; term gestational age between 37 and 42 completed weeks calculated by last menstrual period and or the result of early ultrasound, that is held up to 20 weeks; Minimum age of 18 years; pregnancy with a single fetus alive.

Exclusion Criteria

Smokers who has smoked less than two hours after nicotine influence on catecholamine secretion; Bearers of mental disorders, documented in the medical record, which would influence his decision and autonomy; They reported having ingested caffeine in the last 10 hours, thus altering the secretion of catecholamines; Users of psychoactive drugs, which influence his decision and autonomy.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Expected denouement: Reducing anxiety of pregnant women submitted to treatment with floral therapy. The evaluation of the intensity of anxiety be performed before treatment and thirty minutes after administration of the last dose therapy, is the experimental group or the control group using numeric scale ranging from 0 to 10, 0 being the absence of symptom and 10 the worst possible intensity, vital parameters, blood pressure, pulse, breathing and samples of biological material saliva for dosage of hormones cortisol, beta-endorphin, epinephrine and norepinephrine.<br><br>
Secondary Outcome Measures
NameTimeMethod
Expected denouement: Pain reduction of pregnant women submitted to treatment with floral therapy. The evaluation of pain intensity will be performed prior to therapy and thirty minutes after administration of the last dose therapy, is the experimental group or the control group using numeric scale ranging from 0 to 10, 0 being the absence of symptom and 10 the worst possible intensity, vital parameters, blood pressure, pulse and breathing and samples of biological material saliva for dosage of hormones cortisol, beta-endorphin, epinephrine and norepinephrine<br><br>
© Copyright 2025. All Rights Reserved by MedPath